Literature DB >> 8691983

Decrease in plasma phenylalanine and tyrosine after phenylalanine-tyrosine free amino acid solutions in man.

E A Moja1, V Lucini, F Benedetti, A Lucca.   

Abstract

After an overnight fast, 5 male healthy subjects ingested increasing amounts of a solution containing a fixed proportion of seven essential amino acids (L-isoleucine, 13.3%; L-leucine, 21.0%; L-lysine, 15.2%; L-methionine, 21.0%; L-threonine, 9.5%; L-tryptophan, 4.8% and L-valine, 15.2%) and lacking phenylalanine and tyrosine. The solutions caused a rapid fall in plasma phenylalanine and tyrosine which was proportional to the total amount of amino acids ingested. Following the highest dose administered (31.5 g) plasma phenylalanine and tyrosine fell to a minimum of, respectively, 12.7% and 29.8% the initial levels and remained markedly reduced at 6 hours after treatment. The decrease of tyrosine and phenylalanine levels was associated with a decrease of systolic and diastolic arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691983     DOI: 10.1016/0024-3205(96)00242-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Dietary tyrosine/phenylalanine depletion effects on behavioral and brain signatures of human motivational processing.

Authors:  James M Bjork; Steven J Grant; Gang Chen; Daniel W Hommer
Journal:  Neuropsychopharmacology       Date:  2013-09-02       Impact factor: 7.853

2.  Age moderates the effect of acute dopamine depletion on passive avoidance learning.

Authors:  Mary Katherine Kelm; Charlotte Ann Boettiger
Journal:  Pharmacol Biochem Behav       Date:  2015-01-28       Impact factor: 3.533

3.  Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.

Authors:  N Coupland; L Zedkova; G Sanghera; M Leyton; J M Le Mellédo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

4.  Acute oral administration of a tyrosine and phenylalanine-free amino acid mixture reduces exercise capacity in the heat.

Authors:  Les Tumilty; Glen Davison; Manfred Beckmann; Rhys Thatcher
Journal:  Eur J Appl Physiol       Date:  2013-01-04       Impact factor: 3.078

5.  Serotonin and dopamine differentially affect appetitive and aversive general Pavlovian-to-instrumental transfer.

Authors:  Martin N Hebart; Jan Gläscher
Journal:  Psychopharmacology (Berl)       Date:  2014-07-18       Impact factor: 4.530

6.  Acute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain.

Authors:  Tatiana A Shnitko; Sarah C Taylor; Sierra J Stringfield; Shannon L Zandy; Roberto U Cofresí; James M Doherty; William B Lynch; Charlotte A Boettiger; Rueben A Gonzales; Donita L Robinson
Journal:  Psychopharmacology (Berl)       Date:  2016-03-05       Impact factor: 4.530

7.  Effects of acute dopamine precusor depletion on immediate reward selection bias and working memory depend on catechol-O-methyltransferase genotype.

Authors:  Mary Katherine Kelm; Charlotte A Boettiger
Journal:  J Cogn Neurosci       Date:  2013-08-12       Impact factor: 3.225

8.  The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.

Authors:  Michael A P Bloomfield; Celia J A Morgan; Shitij Kapur; H Valerie Curran; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

Review 9.  Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults.

Authors:  Heather E Webber; Paula Lopez-Gamundi; Sydney N Stamatovich; Harriet de Wit; Margaret C Wardle
Journal:  Neurosci Biobehav Rev       Date:  2020-11-14       Impact factor: 8.989

10.  Acute depletion of dopamine precursors in the human brain: effects on functional connectivity and alcohol attentional bias.

Authors:  Amanda Elton; Monica L Faulkner; Donita L Robinson; Charlotte A Boettiger
Journal:  Neuropsychopharmacology       Date:  2021-03-16       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.